Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Omega Issues Business Update In Conjunction With Capital One Securities 2nd Annual REIT Conference

The presentation can be found at https://www.omegahealthcare.com/investor-relations/news-and-market-data/presentations. The revised COVID-19 Operator Update slides are on pages 11 through 14 of the presentation.
byMichael Horton
January 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

The presentation can be found at https://www.omegahealthcare.com/investor-relations/news-and-market-data/presentations. The revised COVID-19 Operator Update slides are on pages 11 through 14 of the presentation.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Melt Pharmaceuticals’ MELT-300, Midazolam 3mg And Ketamine 50mg Sublingual Tablet, Achieves Top-Line Results In Primary Sedation Endpoint In Phase 2 Pivotal Efficacy And Safety Study

By Benzinga Newsdesk
Today, 2:03 AM
  MELT-300 Statistically Superior for Procedural Sedation Compared to All Comparator Treatment Arms, Including Midazolam 3mg (P=0.0129) and Ketamine 50mg (P=0.0096) MELT-300 Treatment Arm 50% Less Likely to Require Rescue Sedation Compared to Midazolam (P=0.0198)

HROW